$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$145.16M
Market Cap
-
P/E Ratio
-0.16
EPS
$33.66
52 Week High
$0.61
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company headquartered in La Palma, California, specializing in the development of innovative therapies for various cancer types. The firm is committed to addressing significant unmet needs within the oncology space, leveraging advanced scientific methodologies and a rich therapeutic pipeline. With its strategic focus on clinical development, Liminatus Pharma is positioned to make a meaningful impact in the rapidly evolving cancer treatment landscape, presenting a compelling investment opportunity for institutional investors in the biotechnology sector.
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
TSLA
KVUE
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
K
GOOGL
SOFI
WBD
RR
VALE
T
RGTI
BYND
NIO
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RIG
RKLB
JBLU
QBTS
AMD
CIFR
AG
CDE
MTSR
BTBT
SNAP
IREN
NCLH
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
KO
SMCI
WULF
LUV
UBER
CNQ
SOUN
SMR
CLSK
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
TSLA
KVUE
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
K
GOOGL
SOFI
WBD
RR
VALE
T
RGTI
BYND
NIO
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RIG
RKLB
JBLU
QBTS
AMD
CIFR
AG
CDE
MTSR
BTBT
SNAP
IREN
NCLH
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
KO
SMCI
WULF
LUV
UBER
CNQ
SOUN
SMR
CLSK